Upload

Loading icon Loading...

This video is unavailable.

The Growing Threat of Multidrug-Resistant Gonorrhea

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to like Centers for Disease Control and Prevention (CDC)'s video.

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to dislike Centers for Disease Control and Prevention (CDC)'s video.

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to add Centers for Disease Control and Prevention (CDC)'s video to your playlist.

Published on May 16, 2012

Since antibiotics were first used for treatment of gonorrhea, the organism has progressively developed resistance to the sulfa drugs prescribed to treat it. Currently, CDC STD treatment guidelines recommend dual therapy with a cephalosporin antibiotic (ceftriaxone is preferred) and either azithromycin or doxycycline to treat all uncomplicated gonococcal infections among adults and adolescents in the United States.

This session of Grand Rounds explored the development of antibiotic resistance in Neisseria gonorrhoeae as a growing public health concern because the United States gonorrhea control strategy relies on effective antibiotic therapy.

Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/...

This video can also be viewed at
http://www.cdc.gov/about/grand-rounds...

Loading icon Loading...

Loading icon Loading...

Loading icon Loading...

The interactive transcript could not be loaded.

Loading icon Loading...

Loading icon Loading...

Ratings have been disabled for this video.
Rating is available when the video has been rented.
This feature is not available right now. Please try again later.

Loading icon Loading...

Loading...
Working...
to add this to Watch Later

Add to